Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics, Inc. (LXEO) EBIT Margin (2022 - 2023)

Lexeo Therapeutics' EBIT Margin history spans 2 years, with the latest figure at 29948.0% for Q4 2023.

  • For Q4 2023, EBIT Margin changed N/A year-over-year to 29948.0%; the TTM value through Dec 2023 reached 33420.98%, changed N/A, while the annual FY2024 figure was 77201.46%, 4378048.0% up from the prior year.
  • EBIT Margin for Q4 2023 was 29948.0% at Lexeo Therapeutics, down from 38986.54% in the prior quarter.
  • Across five years, EBIT Margin topped out at 38986.54% in Q3 2023 and bottomed at 3292.28% in Q3 2022.